PatientsVille.com Logo

PatientsVille

Bydureon Side Effects

Common Bydureon Side Effects


The most commonly reported Bydureon side effects (click to view or check a box to report):

Injection Site Nodule (430)
Injection Site Haemorrhage (296)
Injection Site Pain (272)
Nausea (266)
Blood Glucose Increased (260)
Weight Decreased (244)
Injection Site Pruritus (220)
Injection Site Swelling (156)
Injection Site Mass (156)
Injection Site Erythema (133)
Off Label Use (131)
Diarrhoea (122)
Vomiting (102)
Decreased Appetite (101)
Injection Site Extravasation (93)
Blood Glucose Decreased (84)
Injection Site Bruising (72)
Dizziness (62)
Constipation (59)
Underdose (56)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Bydureon Side Effects Reported to FDA

The following Bydureon reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Bydureon on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Abdominal Pain, Malaise, Nausea, Vomiting, Constipation, Back Pain, Weight Decreased
This is a report of a 68-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Bydureon (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Abdominal Pain
  • Malaise
  • Nausea
  • Vomiting
  • Constipation
  • Back Pain
  • Weight Decreased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bydureon treatment in female patients, resulting in abdominal pain side effect. The patient was hospitalized.

Needle Issue
This report suggests a potential Bydureon Needle Issue side effect(s) that can have serious consequences. A 30-year-old female patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus and used Bydureon (dosage: NA) starting NS. Soon after starting Bydureon the patient began experiencing various side effects, including:
  • Needle Issue
Drugs used concurrently: NA. Although Bydureon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as needle issue, may still occur.

Parathyroid Tumour, Increased Appetite, Weight Increased, Dyspnoea, Tremor, Hyperhidrosis, Injection Site Reaction
This Parathyroid Tumour, Increased Appetite, Weight Increased, Dyspnoea, Tremor, Hyperhidrosis, Injection Site Reaction problem was reported by a consumer or non-health professional from US. A 59-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On NS this consumer started treatment with Bydureon (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Bydureon, the patient experienced the following unwanted symptoms/side effects:
  • Parathyroid Tumour
  • Increased Appetite
  • Weight Increased
  • Dyspnoea
  • Tremor
  • Hyperhidrosis
  • Injection Site Reaction
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as parathyroid tumour, may become evident only after a product is in use by the general population.

Foot Fracture
This is a report of a 77-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Bydureon (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Foot Fracture
This opens a possibility that Bydureon treatment could cause the above reactions, including foot fracture, and some male subjects may be more susceptible.


Diabetic Ketoacidosis, Decreased Appetite, Nausea, Vomiting
A 56-year-old female patient (weight: NA) from JP with the following symptoms/conditions: diabetes mellitus started Bydureon treatment (dosage: NA) on NS. Soon after starting Bydureon treatment, the subject experienced various side effects, including:
  • Diabetic Ketoacidosis
  • Decreased Appetite
  • Nausea
  • Vomiting
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Bydureon.

Pregnancy, Abortion Induced
A 33-year-old female patient from US (weight: NA) experienced symptoms, such as: NA and was treated with Bydureon(dosage: Auto Inj). The treatment was initiated on Feb 28, 2013. After that a consumer reported the following side effect(s):
  • Pregnancy
  • Abortion Induced
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Bydureon efficacy: NA.

Hepatic Failure
In this report, Bydureon was administered for the following condition: NA.A 60-year-old male consumer from GB (weight: NA) started Bydureon treatment (dosage: NA) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Hepatic Failure
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Bydureon treatment could be related to the listed above side effect(s).

Neuropathy Peripheral, Nausea, Vomiting, Weight Decreased
This is a report of the following Bydureon side effect(s):
  • Neuropathy Peripheral
  • Nausea
  • Vomiting
  • Weight Decreased
A 63-year-old female patient from US (weight: NA) presented with the following condition: type 2 diabetes mellitus and received a treatment with Bydureon (dosage: NA) starting: 201306.The following concurrently used drugs could have generated interactions:
  • Metformin
  • Zofran
  • Zofran
This report suggests that a Bydureon treatment could be associated with the listed above side effect(s).

Renal Cell Carcinoma
This Bydureon report was submitted by a 70-year-old male consumer from DE (weight: NA). The patient was diagnosed with: NA and Bydureon was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Renal Cell Carcinoma
Other drugs used simultaneously: NA.Those unexpected symptoms could be linked to a Bydureon treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Cholelithiasis, Injection Site Nodule, Muscle Spasms
This is a report of a possible correlation between Bydureon use and the following symptoms/side effect(s):
  • Cholelithiasis
  • Injection Site Nodule
  • Muscle Spasms
which could contribute to an assessment of Bydureon risk profile.A 69-year-old female consumer from US (weight: NA) was suffering from NA and was treated with Bydureon (dosage: NA) starting NS.Other concurrent medications:
  • Metformin Hcl (500mg Five Pills Daily (2 Qam, 1 At Lunch, 2 Qpm))
  • Ramipril
  • Diltiazem Cd (Capsule)
  • Allegra
  • Caltrate + D
  • Aspirin
  • Multivitamin
  • Theragran-m


Cardiac Disorder, Renal Impairment, Atrial Fibrillation
A 74-year-old female patient from GB (weight: NA) presented with the following symptoms: NA and after a treatment with Bydureon (dosage: Bydureon 2 Mg Powder And Solvent For Prolonged-release Suspension For Injection?jun/july 2013) experienced the following side effect(s):
  • Cardiac Disorder
  • Renal Impairment
  • Atrial Fibrillation
The treatment was started on 201306. Bydureon was used in combination with the following drugs:
  • Metformin
  • Gliclazide
  • Bisoprolol
  • Cyclizine
  • Digoxin
  • Dihydrocodeine
  • Enoxaparin
  • Furosemide
The patient was hospitalized.This report could alert potential Bydureon consumers.

Eye Operation, Periorbital Contusion
In this report, a 62-year-old female patient from US (weight: NA) was affected by a possible Bydureon side effect.The patient was diagnosed with type 2 diabetes mellitus. After a treatment with Bydureon (dosage: NA, start date: 2013), the patient experienced the following side effect(s):
  • Eye Operation
  • Periorbital Contusion
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Bydureon treatment.


This is a report of a 57-year-old male patient from US (weight: NA), who used Bydureon (dosage: NA) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
    The following drugs could possibly have interacted with the Bydureon treatment NA.Taken together, these observations suggest that a Bydureon treatment could be related to side effect(s), such as .

    Hypotension, Blood Glucose Increased, Loss Of Consciousness, Dizziness, Heart Rate Increased
    This hypotension side effect was reported by a consumer or non-health professional from US. A 63-year-old male patient (weight:NA) experienced the following symptoms/conditions: type 2 diabetes mellitus. The patient was prescribed Bydureon (dosage: NA), which was started on Jan 22, 2014. Concurrently used drugs:
    • Jentadueto (1df = 2.5/1000mg.)
    • Carvedilol
    • Crestor
    • Fenofibrate
    • Pantoprazole
    When starting to take Bydureon the consumer reported the following symptoms:
    • Hypotension
    • Blood Glucose Increased
    • Loss Of Consciousness
    • Dizziness
    • Heart Rate Increased
    These side effects may potentially be related to Bydureon.

    Gastrointestinal Haemorrhage, Mental Status Changes, Hepatic Encephalopathy
    This is a Bydureon side effect report of a 75-year-old male patient (weight:NA) from US, suffering from the following symptoms/conditions: type 2 diabetes mellitus, who was treated with Bydureon (dosage:Second Start Date Of 03-jul-2013, start time: Aug 28, 2013), combined with: NA., and developed a serious reaction and a gastrointestinal haemorrhage side effect. The patient presented with:
    • Gastrointestinal Haemorrhage
    • Mental Status Changes
    • Hepatic Encephalopathy
    which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Bydureon treatment in male patients suffering from type 2 diabetes mellitus, resulting in gastrointestinal haemorrhage.

    Cellulitis
    This report suggests a potential Bydureon cellulitis side effect(s) that can have serious consequences. A 23-year-old female patient from US (weight:NA) was diagnosed with the following health condition(s): type 2 diabetes mellitus and used Bydureon (dosage: NA) starting Sep 27, 2013. Soon after starting Bydureon the patient began experiencing various side effects, including:
    • Cellulitis
    Drugs used concurrently:
    • Metformin
    Although Bydureon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cellulitis, may still occur.

    Foreign Body Reaction, Injection Site Granuloma
    This foreign body reaction problem was reported by a consumer or non-health professional from ES. A 63-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): diabetes mellitus.On Jun 28, 2013 a consumer started treatment with Bydureon (dosage: Int:02-dec-2013). The following drugs/medications were being taken at the same time:
    • Metformin Hcl
    • Losartan
    • Sertraline
    When commencing Bydureon, the patient experienced the following unwanted symptoms /side effects:
    • Foreign Body Reaction
    • Injection Site Granuloma
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as foreign body reaction, may become evident only after a product is in use by the general population.

    Septic Shock, Gastrointestinal Mucosal Disorder, Gastrointestinal Haemorrhage, Decreased Appetite, Dehydration, Nausea, Vomiting
    This is a Bydureon side effect report of a 61-year-old male patient (weight: NA) from JP. The patient developed the following symptoms/conditions: type 2 diabetes mellitus,dementia alzheimer^s type and was treated with Bydureon (dosage: NA) starting 201004. Concurrently used drugs:
    • Donepezil (Donepezil Hydrochloride Od)
    • Metgluco
    • Glimepiride
    • Azilsartan Medoxomil
    • Avonex
    Soon after that, the consumer experienced the following of symptoms:
    • Septic Shock
    • Gastrointestinal Mucosal Disorder
    • Gastrointestinal Haemorrhage
    • Decreased Appetite
    • Dehydration
    • Nausea
    • Vomiting
    The patient was hospitalized. This opens a possibility that Bydureon could cause septic shock and that some male patients may be more susceptible.

    Tremor, Convulsion, Urinary Tract Infection, Hypotension, Nausea, Abdominal Pain, Diarrhoea
    A 61-year-old female patient (weight: NA) from US with the following symptoms: NA started Bydureon treatment (dosage: Last Dose:09dec13) on Dec 09, 2013. Soon after starting Bydureon treatment, the consumer experienced several side effects, including:
    • Tremor
    • Convulsion
    • Urinary Tract Infection
    • Hypotension
    • Nausea
    • Abdominal Pain
    • Diarrhoea
    . Concurrently used drugs:
    • Metformin
    • Humalog
    The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Bydureon side effects, such as tremor.

    Pancreatitis, Headache, Diarrhoea, Injection Site Reaction, Injection Site Pruritus
    This pancreatitis side effect was reported by a consumer or non-health professional from GB. A 57-year-old female patient (weight:NA) experienced the following symptoms/conditions: diabetes mellitus.The patient was prescribed Bydureon (dosage: NA), which was started on NS. Concurrently used drugs: NA..When starting to take Bydureon the consumer reported symptoms, such as:
    • Pancreatitis
    • Headache
    • Diarrhoea
    • Injection Site Reaction
    • Injection Site Pruritus
    These side effects may potentially be related to Bydureon.

    Pancreatitis
    This is a report of a 60-year-old male patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Bydureon (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
    • Pancreatitis
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Bydureon treatment in male patients, resulting in pancreatitis side effect.

    Pancreatitis, Eructation
    This report suggests a potential Bydureon Pancreatitis, Eructation side effect(s) that can have serious consequences. A 47-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus and used Bydureon (dosage: NA) starting Jan 07, 2013. Soon after starting Bydureon the patient began experiencing various side effects, including:
    • Pancreatitis
    • Eructation
    Drugs used concurrently:
    • Insulin
    • Metformin (1df: 500 Units Nos)
    • Invokana
    • Lisinopril (1df: 5 Units Nos)
    • Lantus (1df: 24 Units Nos)
    • Starlix (1df: 120 Units Nos)
    • Crestor (1df: 10 Units Nos)
    Although Bydureon demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as pancreatitis, may still occur.

    Blood Pressure Increased, Weight Increased
    This Blood Pressure Increased, Weight Increased problem was reported by a physician from DE. A 65-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On 201203 this consumer started treatment with Bydureon 2mg Pen Disposable (dosage: NA). The following drugs were being taken at the same time:
    • Lisinopril
    • Metohexal
    • Corinfar
    When commencing Bydureon 2mg Pen Disposable, the patient experienced the following unwanted symptoms/side effects:
    • Blood Pressure Increased
    • Weight Increased
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as blood pressure increased, may become evident only after a product is in use by the general population.

    Pancreatitis, Diarrhoea, Dehydration, Weight Decreased
    This is a report of a 65-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: type 2 diabetes mellitus and was treated with Bydureon (dosage: NA) starting 201307. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
    • Pancreatitis
    • Diarrhoea
    • Dehydration
    • Weight Decreased
    The patient was hospitalized. This opens a possibility that Bydureon treatment could cause the above reactions, including pancreatitis, and some female subjects may be more susceptible.

    Pancreatitis Acute
    A 56-year-old female patient (weight: NA) from US with the following symptoms/conditions: type 2 diabetes mellitus started Bydureon treatment (dosage: NA) on Mar 05, 2013. Soon after starting Bydureon treatment, the subject experienced various side effects, including:
    • Pancreatitis Acute
    Concurrently used drugs:
    • Estropipate
    • Gemfibrozil
    • Loratadine
    • Metoprolol Tartrate
    • Zegerid (1 Caps)
    The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Bydureon.

    1 of 78 



    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Bydureon Side Effects

    Did You Have a Bydureon Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Bydureon for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Bydureon Safety Alerts, Active Ingredients, Usage Information

    NDC0310-6520
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameBYDUREON
    Nameexenatide
    Dosage FormKIT
    Route
    On market since20150201
    LabelerAstraZeneca Pharmaceuticals LP
    Active Ingredient(s)
    Strength(s)
    Unit(s)
    Pharma Class

    More About Bydureon

    Side Effects reported to FDA: 1929

    Bydureon safety alerts: No

    Reported deaths: 4

    Reported hospitalizations: 190

    Latest Bydureon clinical trials

    Bydureon Reviews

    No reviews, be a first to report a side effect via side effect reporting form